Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nephron progenitor cells are a population of kidney-specific stem/progenitor cells essential for kidney development and nephron formation. These cells, marked by expression of SIX2 and NCAM1, are capable of self-renewal and differentiation into all epithelial components of the nephron. While in humans they are naturally present during development and lost before or shortly after birth, recent advances in stem cell technology have enabled the derivation of NPCs from induced pluripotent stem cells for research and therapeutic purposes. Engraftment of NPCs into injured or developing kidneys in animal models has demonstrated their ability to integrate, differentiate, and promote regeneration of kidney structures[2][4][5][3][6]. Cell-based therapies using nephron progenitor cells (human or engineered) are under investigation for the treatment of acute and chronic kidney diseases, offering potential for kidney repair through targeted regeneration and functional restoration.
Engraftment and differentiation into nephron structures Secretion of trophic factors (e.g., VEGF-A) promoting repair and neovascularization[5] Direct replacement of damaged renal epithelial cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nephron progenitor cell (NPC).